Jaret Malloy

Summary

Affiliation: Amylin Pharmaceuticals
Country: USA

Publications

  1. doi request reprint Efficacy and tolerability of exenatide once weekly versus sitagliptin in patients with type 2 diabetes mellitus: a retrospective analysis of pooled clinical trial data
    Jaret Malloy
    Amylin Pharmaceuticals, LLC, San Diego, CA 92121, USA
    Postgrad Med 125:58-67. 2013
  2. doi request reprint Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover study
    Jaret Malloy
    Amylin Pharmaceuticals, Inc, San Diego, California 92121, USA
    Clin Ther 31:806-15. 2009
  3. doi request reprint Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus: an integrated analysis of the DURATION trials
    Michael Grimm
    Amylin Pharmaceuticals, LLC, San Diego, CA 92121, USA
    Postgrad Med 125:47-57. 2013
  4. pmc Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment
    Jennie H Best
    Medical Development, Amylin Pharmaceuticals, San Diego, California, USA
    Diabetes Care 34:314-9. 2011
  5. pmc Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes
    Jaret Malloy
    Amylin Pharmaceuticals LLC, San Diego, CA, USA
    Diabetes Metab Syndr Obes 5:419-24. 2012

Collaborators

Detail Information

Publications5

  1. doi request reprint Efficacy and tolerability of exenatide once weekly versus sitagliptin in patients with type 2 diabetes mellitus: a retrospective analysis of pooled clinical trial data
    Jaret Malloy
    Amylin Pharmaceuticals, LLC, San Diego, CA 92121, USA
    Postgrad Med 125:58-67. 2013
    ....
  2. doi request reprint Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover study
    Jaret Malloy
    Amylin Pharmaceuticals, Inc, San Diego, California 92121, USA
    Clin Ther 31:806-15. 2009
    ..This study assessed the pharmacokinetics, pharmacodynamics, and tolerability of single doses of exenatide in adolescent patients with type 2 diabetes mellitus (T2DM)...
  3. doi request reprint Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus: an integrated analysis of the DURATION trials
    Michael Grimm
    Amylin Pharmaceuticals, LLC, San Diego, CA 92121, USA
    Postgrad Med 125:47-57. 2013
    ..This post hoc analysis pooled data from patients taking EQW across 6 trials to assess efficacy and safety in a large, varied patient population...
  4. pmc Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment
    Jennie H Best
    Medical Development, Amylin Pharmaceuticals, San Diego, California, USA
    Diabetes Care 34:314-9. 2011
    ..To assess change in patient-reported outcomes in subjects with type 2 diabetes treated with exenatide once weekly compared with those treated with sitagliptin or pioglitazone...
  5. pmc Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes
    Jaret Malloy
    Amylin Pharmaceuticals LLC, San Diego, CA, USA
    Diabetes Metab Syndr Obes 5:419-24. 2012
    ..Serum lipase and pancreatic amylase concentrations are used in conjunction with clinical findings to diagnose pancreatitis...